3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Mesothelioma, Malignant
5
Ototoxicity
4
Medulloblastoma
4
Hepatoblastoma
4
Central Nervous System Neoplasms
4
Peritoneal Neoplasms
3
Ovarian Neoplasms
3
Gastrointestinal Neoplasms
3
Drug-Related Side Effects and Adverse Reactions
3
Testicular Neoplasms
2
Stomach Neoplasms
2
Sarcoma
2
Oligodendroglioma
2
Neoplasms, Germ Cell and Embryonal
2
Liver Neoplasms
2
Hearing Loss
2
Glioma
2
Brain Neoplasms
2
Astrocytoma
2
Adrenocortical Carcinoma
2
Thrombocytopenia
1
Teratoma
1
Seminoma
1
Rhabdomyosarcoma
1
Rectal Neoplasms
1
Pelvic Neoplasms
1
Ovarian Germ Cell Cancer
1
Osteosarcoma
1
Oropharyngeal Neoplasms
1
Optic Nerve Glioma
1
Interventions
Carboplatin
158
Paclitaxel
152
Bevacizumab
85
Gemcitabine
48
liposomal doxorubicin
47
Taxes
47
Topotecan
41
Cisplatin
34
pembrolizumab
33
Cyclophosphamide
27
olaparib
25
Immunoglobulin G
24
Disulfides
24
Specimen Handling
20
Docetaxel
20
Drug Therapy
19
Magnetic Resonance Spectroscopy
17
niraparib
16
Doxorubicin
16
Biopsy
15
mirvetuximab soravtansine
14
Hyperthermic Intraperitoneal Chemotherapy
13
rucaparib
12
Nivolumab
12
Cytoreduction Surgical Procedures
10
Albumin-Bound Paclitaxel
10
veliparib
9
Platinum
9
Chemotherapy, Adjuvant
9
130-nm albumin-bound paclitaxel
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Fallopian Tube Neoplasms
×
sodium thiosulfate
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled